Tata Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat NegativeRevenue DeclineExceptional ItemEbitda Margin CompressionResults View source PDF Explain this filing

TATACHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹810.10

prior close

₹790.10

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.2%-1.7% vs market

Commodity Chemicals peers, median of 53sector-0.2%-1.3% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Smallcap 250 and 1.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+1.6

15m

-0.1

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5+0.2-1.7-0.2-1.3

Next day

+0.7+2.0-1.3+0.3+0.4

-0.9+3.0-4.0+1.4-2.3

-3.5+3.2-6.7+0.6-4.1

-6.2+2.1-8.3-0.2-6.0

-4.3-0.9-3.3-2.7-1.5

-6.8-0.6-6.2-1.3-5.5

15d

-3.3+0.7-4.0-0.2-3.1

-11.4+0.9-12.3-1.1-10.2

-13.7+7.0-20.7-2.2-11.5

-17.8+8.4-26.3+1.0-18.8

UpDownMarket · Nifty Smallcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tata Chemicals reported a massive consolidated net loss of ₹1,715 crore for FY26 versus a profit of ₹387 crore in FY25, driven by exceptional items totaling ₹11,956 crore. The exceptional items include a ₹1,837 crore goodwill impairment for US operations due to adverse market conditions and geopolitical headwinds, ₹65 crore additional costs from the UK Lostock plant closure, and ₹54 crore impact from new labour codes. Revenue from operations declined marginally to ₹14,584 crore from ₹14,887 crore. Underlying operating profit before exceptional items was ₹330 crore. The company declared an unchanged dividend of ₹11 per share (110%). Statutory auditors BSR & Co. LLP issued an unmodified opinion on both consolidated and standalone results.

Likely market impact

The exceptional items (primarily goodwill impairment and plant closure costs) resulted in a massive bottom-line loss despite reasonable operational revenue. The ₹1,837 crore impairment signals permanent destruction of shareholder value in the US business. Despite the loss, the dividend payout signals management confidence, but the stock may remain under pressure due to the impairment and ongoing UK closure costs.